Gene expression profiles may be used in patients with ER+ breast cancer to make a distinction between groups with a low or high risk of developing distant metastases in order to optimize patient selection for chemotherapy [6,7,8,9,10,11,12]. Here, ESR1 is linked to breast carcinoma.